WallStreetZenWallStreetZen

NASDAQ: SNY
Sanofi Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Sanofi revenue was $50.74B for the trailing 12 months ending Jun 30, 2025, with 139.6% growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was N/A, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SNY annual revenue was $46.1B, with -0.2% growth year-over-year.

SNY past revenue growth

How has SNY's revenue growth performed historically?

Company
18.08%
Industry
18.32%
Market
21.98%
SNY's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SNY's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SNY's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SNY revenue history

Current Revenue
$50.7B
Current Earnings
$10.7B
Current Profit Margin
21.2%
SNY's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

Be the first to know when SNY announces revenue.

SNY Revenue History By Year

SNY Yearly RevenueSNY RevenueSNY ChangeSNY Revenue Growth
2024-12-31$46.13B-$110.97M-0.24%
2023-12-31$46.24B$3.09B+7.17%
2022-12-31$43.15B-$1.37B-3.07%
2021-12-31$44.52B-$1.05B-2.31%
2020-12-31$45.57B$3.29B+7.78%
2019-12-31$42.28B$1.27B+3.11%
2018-12-31$41.01B-$2.47B-5.69%
2017-12-31$43.48B$6.96B+19.06%
2016-12-31$36.52B-$1.33B-3.51%
2015-12-31$37.85B-$888.46M-2.29%
2014-12-31$38.74B-$4.30B-9.99%
2013-12-31$43.04B-$4.40B-9.27%
2012-12-31$47.44B$2.02B+4.46%
2011-12-31$45.41B-$90.76M-0.20%
2010-12-31$45.50B$693.49M+1.55%
2009-12-31$44.81B$4.67B+11.65%
2008-12-31$40.14B-$2.57B-6.01%
2007-12-31$42.70B$3.90B+10.05%
2006-12-31$38.80B$5.10B+15.13%
2005-12-31$33.70B$12.36B+57.88%
2004-12-31$21.35B$11.21B+110.61%
2003-12-31$10.14B$2.32B+29.69%
2002-12-31$7.82B$2.05B+35.52%
2001-12-31$5.77B$183.78M+3.29%
2000-12-31$5.58BN/AN/A

1 of 2

Sanofi Revenue FAQ

What was SNY's revenue last quarter?

On Invalid Date, Sanofi (NASDAQ: SNY) reported Q2 2025 revenue of N/A up N/A year over year. In the same quarter last year, Sanofi's revenue was N/A.

What was Sanofi's revenue in 2024?

Sanofi's annual revenue for the twelve months ending Dec 31, 2024 was $46.13 billion, a 0.24% decrease year over year.

How much does Sanofi make in a day?

Based on Sanofi annual revenue for the past five years, SNY makes an average of $123,623,270.63 per day.

What was Sanofi's annual revenue growth in the past year?

As of Q4 2025, Sanofi's revenue has grown 18.08% year over year. This is 0.24 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 18.32%. Sanofi's revenue in the past year totaled $50.74 billion.

How much does Sanofi make in a year?

Sanofi's revenue by year for the past five years is:
  • Sanofi's revenue for the twelve months ending Dec 31, 2024 was $46.13 billion, a 0.24% decrease year over year.
  • Sanofi's annual revenue for Dec 31, 2023 was $46.24 billion, a 7.17% increase from 2022.
  • Sanofi's annual revenue for 2022 was $43.15 billion, a 3.07% decrease from 2021.
  • Sanofi's annual revenue for 2021 was $44.52 billion, a 2.31% decrease from 2020.
  • Sanofi's annual revenue for 2020 was $45.57 billion, a 7.78% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.